Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial (Q41080477)
Jump to navigation
Jump to search
scientific article published on 12 June 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial |
scientific article published on 12 June 2017 |
Statements
1 reference
Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial (English)
1 reference
Toshifumi Hibi
1 reference
Nagamu Inoue
1 reference
Kiyonori Kobayashi
1 reference
Makoto Naganuma
1 reference
Fumihito Hirai
1 reference
Morio Ozawa
1 reference
Dilek Arikan
1 reference
Bidan Huang
1 reference
Anne M Robinson
1 reference
Roopal B Thakkar
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference